■ 영문 제목 : Global Transdermal Patches Market 2024-2028
|
 | ■ 상품코드 : IRTNTR77722-24
■ 조사/발행회사 : Technavio
■ 발행일 : 2024년 3월 ■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (주문후 24시간내)
■ 조사대상 지역 : 북미, 유럽, 아시아, 기타 지역
■ 산업 분야 : 의료
|
■ 판매가격 / 옵션
(부가세 10% 별도)
Single User (1인 열람용) | USD2,500 ⇒환산₩3,375,000 | 견적의뢰/주문/질문 |
Enterprise License (기업 열람용) | USD4,000 ⇒환산₩5,400,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
세계의 경피용 패치 시장 2024-2028경피용 패치 시장은 2023년부터 2028년까지 20억 달러 규모로 성장할 것으로 예상되며, 예측 기간 동안 5.65%의 CAGR로 성장할 것으로 전망됩니다.
이 보고서는 경피용 패치 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 그리고 약 25개 벤더에 대한 벤더 분석을 제공합니다.
현재 시장 시나리오, 최신 동향 및 촉진 요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 비침습적 약물 전달 방법에 대한 수요 증가, 만성질환 유병률 증가, 경피용 패치 개발에 대한 투자 증가로 인한 의료비 증가 등이 시장을 주도하고 있습니다.
Technavio사의 경피용 패치 시장은 다음과 같이 구분됩니다.
용도별
- 통증 관리
- 중추신경계 질환
- 호르몬 용도
- 심혈관 질환
- 기타
최종 용도별
- 재택의료
- 병원 및 클리닉
지역별
- 북미
- 유럽
- 아시아
- 기타 지역(ROW)
이 보고서는 향후 수년간 경피용 패치 시장의 성장을 촉진하는 주요 이유 중 하나로 약물 전달 효율을 높이기 위한 마이크로니들 패치의 개발을 꼽고 있습니다. 또한, 경피용 패치의 피부과 및 화장품 분야로의 적용 확대와 패치 제조에 있어 지속 가능한 생분해성 소재의 채택은 시장의 큰 수요를 창출할 것으로 보입니다.
본 보고서는 경피용 패치 시장에 대해 다음과 같은 분야를 다루고 있습니다.
- 경피용 패치 시장 규모
- 경피용 패치 시장 예측
- 경피용 패치 시장 산업 분석
이 보고서는 경피용 패치 시장의 주요 업체인 Alvogen Iceland ehf, Boehringer Ingelheim International GmbH, Endo International Plc, Kyuko Pharmaceutical Co. Johnson Services Inc., Luye Pharma Group Ltd., Medherant Ltd., Mundipharma International Ltd, Sparsha Pharma International Pvt. Ltd, Teva Pharmaceutical Industries Ltd, Viatris Inc, AdhexPharma SAS, Agile Therapeutics Inc, Evernow Inc. 등의 정보를 수록하고 있습니다. 또한 경피용 패치 시장 분석 보고서에는 시장 성장에 영향을 미치는 향후 동향과 과제에 대한 정보도 포함되어 있습니다. 이는 기업이 전략을 수립하고 다가오는 모든 성장 기회를 활용하는 데 도움이 될 것입니다.
이 조사는 업계 주요 참여자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서에는 주요 벤더 분석과 함께 포괄적인 시장 및 벤더 현황이 수록되어 있습니다.
이익, 가격, 경쟁, 프로모션 등 주요 매개변수 분석을 통해 여러 출처의 데이터를 조사, 통합 및 요약하여 시장의 세부적인 모습을 제시합니다. 업계의 주요 영향력을 파악하여 시장의 다양한 측면을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해 완전한 경쟁 환경과 정성적 및 정량적 조사를 통한 면밀한 공급업체 선정 방법 및 분석을 제공합니다. |
■ 보고서 개요1. 개요
2. 시장 현황
3. 시장 규모
4. 과거 시장 규모
5. 파이브 포스 분석
6. 세계의 경피용 패치 시장 규모 : 용도별
7. 세계의 경피용 패치 시장 규모 : 최종 용도별
8. 고객 현황
9. 지리적 현황
10. 추진 요인, 과제, 동향
11. 기업 현황
12. 기업 분석
13. 부록
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global transdermal patches market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global transdermal patches market 2018 – 2022 ($ billion)
o 4.2 Application Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Application Segment 2018 – 2022 ($ billion)
o 4.3 End User Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – End User Segment 2018 – 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 22: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 23: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 24: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 25: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 26: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 27: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 28: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 29: Chart on Application – Market share 2023-2028 (%)
o Exhibit 30: Data Table on Application – Market share 2023-2028 (%)
o 6.2 Comparison by Application
o Exhibit 31: Chart on Comparison by Application
o Exhibit 32: Data Table on Comparison by Application
o 6.3 Pain management – Market size and forecast 2023-2028
o Exhibit 33: Chart on Pain management – Market size and forecast 2023-2028 ($ billion)
o Exhibit 34: Data Table on Pain management – Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Chart on Pain management – Year-over-year growth 2023-2028 (%)
o Exhibit 36: Data Table on Pain management – Year-over-year growth 2023-2028 (%)
o 6.4 Central nervous system disorders – Market size and forecast 2023-2028
o Exhibit 37: Chart on Central nervous system disorders – Market size and forecast 2023-2028 ($ billion)
o Exhibit 38: Data Table on Central nervous system disorders – Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Chart on Central nervous system disorders – Year-over-year growth 2023-2028 (%)
o Exhibit 40: Data Table on Central nervous system disorders – Year-over-year growth 2023-2028 (%)
o 6.5 Hormonal application – Market size and forecast 2023-2028
o Exhibit 41: Chart on Hormonal application – Market size and forecast 2023-2028 ($ billion)
o Exhibit 42: Data Table on Hormonal application – Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Chart on Hormonal application – Year-over-year growth 2023-2028 (%)
o Exhibit 44: Data Table on Hormonal application – Year-over-year growth 2023-2028 (%)
o 6.6 Cardiovascular diseases – Market size and forecast 2023-2028
o Exhibit 45: Chart on Cardiovascular diseases – Market size and forecast 2023-2028 ($ billion)
o Exhibit 46: Data Table on Cardiovascular diseases – Market size and forecast 2023-2028 ($ billion)
o Exhibit 47: Chart on Cardiovascular diseases – Year-over-year growth 2023-2028 (%)
o Exhibit 48: Data Table on Cardiovascular diseases – Year-over-year growth 2023-2028 (%)
o 6.7 Others – Market size and forecast 2023-2028
o Exhibit 49: Chart on Others – Market size and forecast 2023-2028 ($ billion)
o Exhibit 50: Data Table on Others – Market size and forecast 2023-2028 ($ billion)
o Exhibit 51: Chart on Others – Year-over-year growth 2023-2028 (%)
o Exhibit 52: Data Table on Others – Year-over-year growth 2023-2028 (%)
o 6.8 Market opportunity by Application
o Exhibit 53: Market opportunity by Application ($ billion)
o Exhibit 54: Data Table on Market opportunity by Application ($ billion)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 55: Chart on End-user – Market share 2023-2028 (%)
o Exhibit 56: Data Table on End-user – Market share 2023-2028 (%)
o 7.2 Comparison by End-user
o Exhibit 57: Chart on Comparison by End-user
o Exhibit 58: Data Table on Comparison by End-user
o 7.3 Homecare – Market size and forecast 2023-2028
o Exhibit 59: Chart on Homecare – Market size and forecast 2023-2028 ($ billion)
o Exhibit 60: Data Table on Homecare – Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Chart on Homecare – Year-over-year growth 2023-2028 (%)
o Exhibit 62: Data Table on Homecare – Year-over-year growth 2023-2028 (%)
o 7.4 Hospitals and clinics – Market size and forecast 2023-2028
o Exhibit 63: Chart on Hospitals and clinics – Market size and forecast 2023-2028 ($ billion)
o Exhibit 64: Data Table on Hospitals and clinics – Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Chart on Hospitals and clinics – Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on Hospitals and clinics – Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by End-user
o Exhibit 67: Market opportunity by End-user ($ billion)
o Exhibit 68: Data Table on Market opportunity by End-user ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 70: Chart on Market share by geography 2023-2028 (%)
o Exhibit 71: Data Table on Market share by geography 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 72: Chart on Geographic comparison
o Exhibit 73: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 74: Chart on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 75: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 77: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 78: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 79: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 81: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 82: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 83: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 85: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 86: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 87: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 89: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 90: Chart on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 91: Data Table on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 93: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 China – Market size and forecast 2023-2028
o Exhibit 94: Chart on China – Market size and forecast 2023-2028 ($ billion)
o Exhibit 95: Data Table on China – Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 97: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.9 Germany – Market size and forecast 2023-2028
o Exhibit 98: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 99: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 101: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.10 UK – Market size and forecast 2023-2028
o Exhibit 102: Chart on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 103: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 105: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.11 Japan – Market size and forecast 2023-2028
o Exhibit 106: Chart on Japan – Market size and forecast 2023-2028 ($ billion)
o Exhibit 107: Data Table on Japan – Market size and forecast 2023-2028 ($ billion)
o Exhibit 108: Chart on Japan – Year-over-year growth 2023-2028 (%)
o Exhibit 109: Data Table on Japan – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity by geography
o Exhibit 110: Market opportunity by geography ($ billion)
o Exhibit 111: Data Tables on Market opportunity by geography ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 112: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 113: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 114: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 115: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 116: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 117: Matrix on vendor position and classification
o 12.3 Agile Therapeutics Inc.
o Exhibit 118: Agile Therapeutics Inc. – Overview
o Exhibit 119: Agile Therapeutics Inc. – Product / Service
o Exhibit 120: Agile Therapeutics Inc. – Key offerings
o 12.4 Alvogen Iceland ehf
o Exhibit 121: Alvogen Iceland ehf – Overview
o Exhibit 122: Alvogen Iceland ehf – Product / Service
o Exhibit 123: Alvogen Iceland ehf – Key offerings
o 12.5 Bayer AG
o Exhibit 124: Bayer AG – Overview
o Exhibit 125: Bayer AG – Business segments
o Exhibit 126: Bayer AG – Key news
o Exhibit 127: Bayer AG – Key offerings
o Exhibit 128: Bayer AG – Segment focus
o 12.6 Boehringer Ingelheim International GmbH
o Exhibit 129: Boehringer Ingelheim International GmbH – Overview
o Exhibit 130: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 131: Boehringer Ingelheim International GmbH – Key news
o Exhibit 132: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 133: Boehringer Ingelheim International GmbH – Segment focus
o 12.7 Endo International Plc
o Exhibit 134: Endo International Plc – Overview
o Exhibit 135: Endo International Plc – Business segments
o Exhibit 136: Endo International Plc – Key news
o Exhibit 137: Endo International Plc – Key offerings
o Exhibit 138: Endo International Plc – Segment focus
o 12.8 Hisamitsu Pharmaceutical Co. Inc.
o Exhibit 139: Hisamitsu Pharmaceutical Co. Inc. – Overview
o Exhibit 140: Hisamitsu Pharmaceutical Co. Inc. – Product / Service
o Exhibit 141: Hisamitsu Pharmaceutical Co. Inc. – Key offerings
o 12.9 IontoPatch
o Exhibit 142: IontoPatch – Overview
o Exhibit 143: IontoPatch – Key offerings
o 12.10 Johnson and Johnson Services Inc.
o Exhibit 144: Johnson and Johnson Services Inc. – Overview
o Exhibit 145: Johnson and Johnson Services Inc. – Business segments
o Exhibit 146: Johnson and Johnson Services Inc. – Key news
o Exhibit 147: Johnson and Johnson Services Inc. – Key offerings
o Exhibit 148: Johnson and Johnson Services Inc. – Segment focus
o 12.11 Lead Chemical Co. Ltd.
o Exhibit 149: Lead Chemical Co. Ltd. – Overview
o Exhibit 150: Lead Chemical Co. Ltd. – Product / Service
o Exhibit 151: Lead Chemical Co. Ltd. – Key offerings
o 12.12 Luye Pharma Group Ltd.
o Exhibit 152: Luye Pharma Group Ltd. – Overview
o Exhibit 153: Luye Pharma Group Ltd. – Business segments
o Exhibit 154: Luye Pharma Group Ltd. – Key offerings
o Exhibit 155: Luye Pharma Group Ltd. – Segment focus
o 12.13 Nitto Denko Corp.
o Exhibit 156: Nitto Denko Corp. – Overview
o Exhibit 157: Nitto Denko Corp. – Business segments
o Exhibit 158: Nitto Denko Corp. – Key offerings
o Exhibit 159: Nitto Denko Corp. – Segment focus
o 12.14 Novartis AG
o Exhibit 160: Novartis AG – Overview
o Exhibit 161: Novartis AG – Business segments
o Exhibit 162: Novartis AG – Key news
o Exhibit 163: Novartis AG – Key offerings
o Exhibit 164: Novartis AG – Segment focus
o 12.15 Purdue Pharma LP
o Exhibit 165: Purdue Pharma LP – Overview
o Exhibit 166: Purdue Pharma LP – Product / Service
o Exhibit 167: Purdue Pharma LP – Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 168: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 169: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 170: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 171: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 172: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Viatris Inc.
o Exhibit 173: Viatris Inc. – Overview
o Exhibit 174: Viatris Inc. – Business segments
o Exhibit 175: Viatris Inc. – Key news
o Exhibit 176: Viatris Inc. – Key offerings
o Exhibit 177: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 178: Inclusions checklist
o Exhibit 179: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 180: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 181: Research methodology
o Exhibit 182: Validation techniques employed for market sizing
o Exhibit 183: Information sources
o 13.5 List of abbreviations
o Exhibit 184: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global transdermal patches market 2018 – 2022 ($ billion)
Exhibits19: Historic Market Size – Application Segment 2018 – 2022 ($ billion)
Exhibits20: Historic Market Size – End User Segment 2018 – 2022 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
Exhibits22: Five forces analysis – Comparison between 2023 and 2028
Exhibits23: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits24: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits25: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits26: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits27: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits28: Chart on Market condition – Five forces 2023 and 2028
Exhibits29: Chart on Application – Market share 2023-2028 (%)
Exhibits30: Data Table on Application – Market share 2023-2028 (%)
Exhibits31: Chart on Comparison by Application
Exhibits32: Data Table on Comparison by Application
Exhibits33: Chart on Pain management – Market size and forecast 2023-2028 ($ billion)
Exhibits34: Data Table on Pain management – Market size and forecast 2023-2028 ($ billion)
Exhibits35: Chart on Pain management – Year-over-year growth 2023-2028 (%)
Exhibits36: Data Table on Pain management – Year-over-year growth 2023-2028 (%)
Exhibits37: Chart on Central nervous system disorders – Market size and forecast 2023-2028 ($ billion)
Exhibits38: Data Table on Central nervous system disorders – Market size and forecast 2023-2028 ($ billion)
Exhibits39: Chart on Central nervous system disorders – Year-over-year growth 2023-2028 (%)
Exhibits40: Data Table on Central nervous system disorders – Year-over-year growth 2023-2028 (%)
Exhibits41: Chart on Hormonal application – Market size and forecast 2023-2028 ($ billion)
Exhibits42: Data Table on Hormonal application – Market size and forecast 2023-2028 ($ billion)
Exhibits43: Chart on Hormonal application – Year-over-year growth 2023-2028 (%)
Exhibits44: Data Table on Hormonal application – Year-over-year growth 2023-2028 (%)
Exhibits45: Chart on Cardiovascular diseases – Market size and forecast 2023-2028 ($ billion)
Exhibits46: Data Table on Cardiovascular diseases – Market size and forecast 2023-2028 ($ billion)
Exhibits47: Chart on Cardiovascular diseases – Year-over-year growth 2023-2028 (%)
Exhibits48: Data Table on Cardiovascular diseases – Year-over-year growth 2023-2028 (%)
Exhibits49: Chart on Others – Market size and forecast 2023-2028 ($ billion)
Exhibits50: Data Table on Others – Market size and forecast 2023-2028 ($ billion)
Exhibits51: Chart on Others – Year-over-year growth 2023-2028 (%)
Exhibits52: Data Table on Others – Year-over-year growth 2023-2028 (%)
Exhibits53: Market opportunity by Application ($ billion)
Exhibits54: Data Table on Market opportunity by Application ($ billion)
Exhibits55: Chart on End-user – Market share 2023-2028 (%)
Exhibits56: Data Table on End-user – Market share 2023-2028 (%)
Exhibits57: Chart on Comparison by End-user
Exhibits58: Data Table on Comparison by End-user
Exhibits59: Chart on Homecare – Market size and forecast 2023-2028 ($ billion)
Exhibits60: Data Table on Homecare – Market size and forecast 2023-2028 ($ billion)
Exhibits61: Chart on Homecare – Year-over-year growth 2023-2028 (%)
Exhibits62: Data Table on Homecare – Year-over-year growth 2023-2028 (%)
Exhibits63: Chart on Hospitals and clinics – Market size and forecast 2023-2028 ($ billion)
Exhibits64: Data Table on Hospitals and clinics – Market size and forecast 2023-2028 ($ billion)
Exhibits65: Chart on Hospitals and clinics – Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on Hospitals and clinics – Year-over-year growth 2023-2028 (%)
Exhibits67: Market opportunity by End-user ($ billion)
Exhibits68: Data Table on Market opportunity by End-user ($ billion)
Exhibits69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits70: Chart on Market share by geography 2023-2028 (%)
Exhibits71: Data Table on Market share by geography 2023-2028 (%)
Exhibits72: Chart on Geographic comparison
Exhibits73: Data Table on Geographic comparison
Exhibits74: Chart on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits75: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits76: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits77: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits78: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits79: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits80: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits81: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits82: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits83: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits84: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits85: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits86: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits87: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits88: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits89: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits90: Chart on US – Market size and forecast 2023-2028 ($ billion)
Exhibits91: Data Table on US – Market size and forecast 2023-2028 ($ billion)
Exhibits92: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits93: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits94: Chart on China – Market size and forecast 2023-2028 ($ billion)
Exhibits95: Data Table on China – Market size and forecast 2023-2028 ($ billion)
Exhibits96: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits97: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits98: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits99: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits100: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits101: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits102: Chart on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits103: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits104: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits105: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits106: Chart on Japan – Market size and forecast 2023-2028 ($ billion)
Exhibits107: Data Table on Japan – Market size and forecast 2023-2028 ($ billion)
Exhibits108: Chart on Japan – Year-over-year growth 2023-2028 (%)
Exhibits109: Data Table on Japan – Year-over-year growth 2023-2028 (%)
Exhibits110: Market opportunity by geography ($ billion)
Exhibits111: Data Tables on Market opportunity by geography ($ billion)
Exhibits112: Impact of drivers and challenges in 2023 and 2028
Exhibits113: Overview on Criticality of inputs and Factors of differentiation
Exhibits114: Overview on factors of disruption
Exhibits115: Impact of key risks on business
Exhibits116: Vendors covered
Exhibits117: Matrix on vendor position and classification
Exhibits118: Agile Therapeutics Inc. – Overview
Exhibits119: Agile Therapeutics Inc. – Product / Service
Exhibits120: Agile Therapeutics Inc. – Key offerings
Exhibits121: Alvogen Iceland ehf – Overview
Exhibits122: Alvogen Iceland ehf – Product / Service
Exhibits123: Alvogen Iceland ehf – Key offerings
Exhibits124: Bayer AG – Overview
Exhibits125: Bayer AG – Business segments
Exhibits126: Bayer AG – Key news
Exhibits127: Bayer AG – Key offerings
Exhibits128: Bayer AG – Segment focus
Exhibits129: Boehringer Ingelheim International GmbH – Overview
Exhibits130: Boehringer Ingelheim International GmbH – Business segments
Exhibits131: Boehringer Ingelheim International GmbH – Key news
Exhibits132: Boehringer Ingelheim International GmbH – Key offerings
Exhibits133: Boehringer Ingelheim International GmbH – Segment focus
Exhibits134: Endo International Plc – Overview
Exhibits135: Endo International Plc – Business segments
Exhibits136: Endo International Plc – Key news
Exhibits137: Endo International Plc – Key offerings
Exhibits138: Endo International Plc – Segment focus
Exhibits139: Hisamitsu Pharmaceutical Co. Inc. – Overview
Exhibits140: Hisamitsu Pharmaceutical Co. Inc. – Product / Service
Exhibits141: Hisamitsu Pharmaceutical Co. Inc. – Key offerings
Exhibits142: IontoPatch – Overview
Exhibits143: IontoPatch – Key offerings
Exhibits144: Johnson and Johnson Services Inc. – Overview
Exhibits145: Johnson and Johnson Services Inc. – Business segments
Exhibits146: Johnson and Johnson Services Inc. – Key news
Exhibits147: Johnson and Johnson Services Inc. – Key offerings
Exhibits148: Johnson and Johnson Services Inc. – Segment focus
Exhibits149: Lead Chemical Co. Ltd. – Overview
Exhibits150: Lead Chemical Co. Ltd. – Product / Service
Exhibits151: Lead Chemical Co. Ltd. – Key offerings
Exhibits152: Luye Pharma Group Ltd. – Overview
Exhibits153: Luye Pharma Group Ltd. – Business segments
Exhibits154: Luye Pharma Group Ltd. – Key offerings
Exhibits155: Luye Pharma Group Ltd. – Segment focus
Exhibits156: Nitto Denko Corp. – Overview
Exhibits157: Nitto Denko Corp. – Business segments
Exhibits158: Nitto Denko Corp. – Key offerings
Exhibits159: Nitto Denko Corp. – Segment focus
Exhibits160: Novartis AG – Overview
Exhibits161: Novartis AG – Business segments
Exhibits162: Novartis AG – Key news
Exhibits163: Novartis AG – Key offerings
Exhibits164: Novartis AG – Segment focus
Exhibits165: Purdue Pharma LP – Overview
Exhibits166: Purdue Pharma LP – Product / Service
Exhibits167: Purdue Pharma LP – Key offerings
Exhibits168: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits169: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits170: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits171: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits172: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits173: Viatris Inc. – Overview
Exhibits174: Viatris Inc. – Business segments
Exhibits175: Viatris Inc. – Key news
Exhibits176: Viatris Inc. – Key offerings
Exhibits177: Viatris Inc. – Segment focus
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations
|
※본 조사보고서 [세계의 경피용 패치 시장 2024-2028 : 통증 관리, 중추 신경계 질환, 호르몬, 심혈관 질환, 기타] (코드 : IRTNTR77722-24) 판매에 관한 면책사항을 반드시 확인하세요. |
※본 조사보고서 [세계의 경피용 패치 시장 2024-2028 : 통증 관리, 중추 신경계 질환, 호르몬, 심혈관 질환, 기타] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!